According to NuCana
's latest financial reports the company has $21.92 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $50.79 M | -37.55% |
2021-12-31 | $81.34 M | -31.68% |
2020-12-31 | $0.11 B | 74.75% |
2019-12-31 | $68.13 M | -30.26% |
2018-12-31 | $97.7 M | -16.63% |
2017-12-31 | $0.11 B | 374.72% |
2016-12-31 | $24.68 M | -42.93% |
2015-12-31 | $43.25 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | $0.20 B | 849.44% | ๐บ๐ธ USA |